MINI REVIEW article
Front. Cell. Neurosci.
Sec. Cellular Neurophysiology
Volume 19 - 2025 | doi: 10.3389/fncel.2025.1617006
This article is part of the Research TopicReviews in Cellular Neurophysiology 2025View all 3 articles
Reduction of the Ca 2+ permeability of ligand-gated ion channels as a strategy against excitotoxicity
Provisionally accepted- 1Mediterranean Neurological Institute Neuromed (IRCCS), Pozzilli, Italy
- 2Sapienza University of Rome, Rome, Italy
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Excitotoxic damage is due to an excessive Ca 2+ entry in cells following overactivation of Ca 2+ -permeable ion channels. In neurons, Ca 2+ -dependent excitotoxicity is linked to the prominent activation of N-Methyl-d-Aspartate receptors (NMDARs), exhibiting a high permeability to Ca 2+ . Different neurodegenerative diseases share glutamate-and NMDAR-dependent excitotoxicity as a pathogenic mechanism, but also different ligandgated ion channels (LGICs) may be involved in excitotoxic-related pathologies, such as muscle nicotinic acetylcholine receptor in some forms of congenital myasthenic syndrome. We posit that excitotoxicity due to the overactivation of Ca 2+ -permeable LGICs may be counteracted by using molecules able to reduce selectively the Ca 2+ entry, without blocking Na + influx, thus reducing the adverse effects induced by channel blockers. In this review, we recapitulate: i) the techniques used to quantify the Ca 2+ permeability of LGICs, with a particular focus on the fractional Ca 2+ current (Pf, i.e. the percentage of the total current carried by Ca 2+ ); ii) the known Pf values of the main LGICs; iii) the modulation of the LGIC Pf values induced by drugs and measured to date. These data support the possibility of fighting excitotoxicity-related pathologies with a new therapeutic approach.
Keywords: Neuroprotection, neurodegeneration, NMDA receptor, nicotinic acetylcholine receptor, fractional Ca 2+ current ROS scavengers No Yes Yes
Received: 23 Apr 2025; Accepted: 02 Jul 2025.
Copyright: © 2025 D'andrea and Fucile. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Sergio Fucile, Sapienza University of Rome, Rome, Italy
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.